BRAIN Biotech AG
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
BRAIN Biotech AG is a German industrial biotechnology company that specializes in the development and production of innovative bio-based products and technologies. Founded in 1993, the company is headquartered in Zwingenberg, Germany, and has several subsidiaries and partnerships all over the world. BRAIN Biotech AG is a leader in the field of white biotechnology and focuses on using natural resources like microorganisms, enzymes, and bioactive compounds to develop sustainable solutions for industries ranging from agriculture to health. The company's technologies are used in applications as diverse as cosmetics, nutrition, pharmaceuticals, and chemicals. BRAIN Biotech AG's products and technologies are tailored to meet the specific requirements of its customers, ranging from large multinational corporations to small and medium-sized enterprises.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for BRAIN Biotech AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-23 08:30 |
Board/Management Information
Experienced biotechnology expert joins the Supervisory Board of BRAIN Biotech AG
|
English | 13.4 KB | |
| 2025-06-23 08:05 |
Share Issue/Capital Change
Price range set: Brainlab targets a market capitalization of c. EUR 1.67 billio…
|
English | 22.4 KB | |
| 2025-05-28 07:30 |
Earnings Release
BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
|
English | 20.0 KB | |
| 2025-05-28 00:00 |
Interim Report
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2024 bis zum 31.03…
|
German | 99.2 KB | |
| 2025-05-28 00:00 |
Interim Report
Half-yearly financial report 2024/2025
|
English | 364.5 KB | |
| 2025-05-21 10:00 |
M&A Activity
BRAIN Biotech announces buy-out of minorities, new continental European product…
|
English | 16.2 KB | |
| 2025-05-19 11:23 |
Report Publication Announcement
|
English | 4.1 KB | |
| 2025-05-19 00:00 |
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
|
German | 5.8 KB | |
| 2025-05-19 00:00 |
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
|
German | 5.8 KB | |
| 2025-04-30 17:54 |
Earnings Release
BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservati…
|
English | 6.0 KB | |
| 2025-03-19 16:45 |
Post-Annual General Meeting Information
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BR…
|
English | 14.6 KB | |
| 2025-03-18 16:45 |
Post-Annual General Meeting Information
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BR…
|
English | 14.6 KB | |
| 2025-03-04 11:25 |
Director's Dealing
BRAIN Biotech AG: Michael Schneiders, buy
|
English | 6.0 KB | |
| 2025-03-03 11:25 |
Director's Dealing
BRAIN Biotech AG: Michael Schneiders, buy
|
English | 6.0 KB | |
| 2025-02-27 07:30 |
Earnings Release
BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growt…
|
English | 20.8 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Can-Fite BioPharma Ltd. | Israel | CANF | |
|
Cantargia | Sweden | CANTA | |
|
Captor Therapeutics S.A. | Poland | CTX | |
|
Carbiotix AB | Sweden | CRBX | |
|
Cellectis | France | ALCLS | |
|
CELLULAR GOODS PLC | United Kingdom | CBX | |
|
Celyad Oncology SA | Belgium | CYAD | |
|
Cereno Scientific AB | Sweden | CRNO | |
|
Cessatech A/S | Denmark | CESSA | |
|
CHOSA Oncology AB | Sweden | CHOSA |